In this study, a simple and selective gas chromatography -mass spectrometry method was developed and validated for the determination of pogostone in canine plasma. Liquid -liquid extraction was used to separate pogostone from canine plasma, and the mean extraction recovery rates of pogostone and the internal standard (isoalantolactone) were 80.61 and 75.89%, respectively. Plastic centrifuge tubes were inadequate for the plasma sample treatment procedure because of the adsorption effect of pogostone on the inner surface. The chromatographic separation was performed on a capillary column of Agilent HP-5ms, and the spectrometer was operated in an electron-impact ionization with an electron multiplier voltage mode. The standard curve was linear over the concentration range of 1.02-406 ng/mL (r > 0.99). The intra-and interday accuracies for pogostone at four concentrations were 97.77-99.92% and 98.51-100.22%, respectively. The relative standard deviations were <15%. The method was successfully applied to a pharmacokinetic study after the oral administration of pogostone to beagle dogs.
Introduction
Pogostemonis Herba is the dried aerial part of Pogostemon cablin (Blanco) Benth, which is well known to be used as Chinese herbal medicine "Guang Huoxiang" to remove dampness, relieve sunstroke, stop vomiting and stimulate the appetite (1) . Pogostemonis Herba has been demonstrated to possess a variety of pharmacological activities (2-6). Pogostone (C 12 H 16 O 4 , the chemical structure is shown in Figure 1A ) is one of the major chemical constituents and a chemical marker of the essential oil of Pogostemonis Herba. Pogostone exerts potent anti-bacterial (7) and anti-fungal (8, 9) activities, and shows anti-candida activity in vitro and in vivo (10) .
At present, a few studies have been published for the determination of pogostone by many modern analytical techniques, including gas chromatography (GC) (11) (12) (13) (14) , high-performance liquid chromatography (HPLC) (10, 15) , GC-mass spectrometry (GC-MS) (13, 14, 16) , two-dimensional GC (GC Â GC) (17) , two-dimensional GC-time-of-flight mass spectrometry (GC Â GC-TOF) (18) and liquid chromatography -tandem mass spectrometry (LC -MS/MS) (19) . Many studies of them (11) (12) (13) (14) (15) (16) (17) (18) did not involve biological sample treatment procedure and the values of limit of quantification (LOQ) were too high. Though GC -MS (13 -15) was already used to analyze the essential oil of Pogostemonis Herba, the biological sample was unconcerned. Only two studies have analyzed biological samples (murine plasma) by HPLC (10) and LC-MS/MS (19) . The values of LOQ, however, are still high and LC -MS/MS is costly. Furthermore, pogostone has good thermal stability (boiling point: 381.5318C at 760 mmHg) and less polar, which makes it more suitable as a hard ionization source, e.g., electron-impact (EI) ionization. Therefore, in the present study, a more sensitive, reliable and cost-effective GC-MS method was developed and validated for the determination of pogostone in canine plasma and was successfully applied to a pharmacokinetic study in beagle dogs following the oral administration of pogostone.
Materials and methods

Materials
Pogostone (99.8%) was kindly supplied by Liang Xiong in our research group, which was extracted from Pogostemonis Herba. Isoalantolactone used as the internal standard (IS; Figure 1B ) was obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, PR China). Methanol was purchased from TEDIA Company (Fairfield, IA, USA), and ethyl acetate was obtained from ARK Chemical (Chengdu, China). Water was made by distillation in glass and passage through a Milli-Q plotwater purification system (Millipore, Bedford, MA, USA). Methanol and water were HPLC grade. Ethyl acetate was analytical reagent and redistilled. Other reagents were analytical pure.
Equipment and GC-MS condition GC-MS was performed with an Agilent 7890A GC instrument, an Agilent 5975C mass spectrometer and Agilent ChemStation software (Agilent Technologies, Palo Alto, CA, USA). Compounds were separated on a capillary column of Agilent HP-5ms (30 m Â 0.25 mm i.d. Â 0.25 mm, coated with film 5% phenyl methyl siloxane). The column temperature was at 1108C for injection; the temperature program began at 258C min 21 to 2408C and held for 1 min, then at 358C min 21 to 2808C and held for 2 min. The spectrometer was operated in EI ionization, and the inlet ionization source temperature was 2308C. The electron multiplier voltage (EMV) mode with a gain factor of 1.01 was used, and the actual EMV was 1576.47 V. Two product ion mass spectra of the base ion peaks at m/z 168.0 and m/z 190.1 of pogostone, and IS were acquired with selected ion monitoring.
Preparation of standard and quality control samples
The standard curves of pogostone in plasma were 1.02, 5.03, 10.2, 50.3, 102, 203 and 406 ng/mL. The concentration of IS in plasma was 0.503 mg/mL. Quality control (QC) samples were 
Sample treatment
Control (blank) plasma was obtained from blank dogs for calibration, and bulk spiked QC samples were removed from the freezer and allowed to thaw to room temperature before extraction. Control plasma with a volume of 270 mL (200 mL of blank plasma spiked with 50 mL of working standard solutions of various concentrations and 20 mL of the IS solution) and sample plasma with a volume of 270 mL (200 mL of sample plasma added to 70 mL of methanol) were prepared for the extraction. Then a sample was extracted using 2 mL of ethyl acetate in a vortex shaker (Vortex Genius 3, IKA-Werke GmbH & Co., Staufen, Germany). The upper organic phase was transferred and 
of isoalantolactone (B).
A Gas Chromatography-Mass Spectrometry Method 1153 evaporated to dryness under a stream of nitrogen at 308C (N-EVAP 11,155, Organomation Associates, Inc., Berlin, MA, USA). The residue was reconstituted in 100 mL of methanol. The sample was transferred to the glass autosampler vial insert and 1 mL was injected into the chromatographic system. During the whole process of sample treatment, glass centrifuge tubes were used instead of plastic tubes.
Pharmacokinetic study
The animal protocol was approved by the Committee of Scientific Research and the Committee of Animal Care of the Chengdu University of Traditional Chinese Medicine (Chengdu, China).
Six beagle dogs (three males and three females), weighing 9 -11 kg, were purchased from GLP Experiment Center of Sichuan Provincial Hospital (Sichuan, China). All dogs were fasted for 12 h before dosing and for another 4 h after dosing. Water was provided ad libitum. Each dog had a lavage of a single dose of pogostone. Blood samples ( 3 mL) were withdrawn from the forelimb veins of each dog before dosing and at 5, 15, 30 and 45 min, and 1, 2, 4, 6, 9, 12 and 16, 24 h after dosing into glass centrifuge tubes (Vacutainer, Zhenjiang Gongdong Medicao Technology Co., Ltd.). The heparinized blood was centrifuged at 4,500 rpm for 10 min and the plasma in the upper layer was transferred and stored at 2208C until analysis. The C max and T max were observed visually from the plots of pogostone plasma concentration versus time. All data were processed using Phoenix WinNonlin 6.3 (Pharsight Corporation, USA) to construct pharmacokinetic profiles.
Results
Method validation
The assay method was validated in terms of selectivity, linearity, sensitivity, accuracy, precision, extraction recovery and stability, according to the Food and Drug Administration guidelines (20) . The mass chromatograms of GC -MS analysis of pogostone and IS are shown in Figure 2A and B, respectively. By the proper procedure, accurate determination and optimal chromatographic peak of pogostone in dog plasma samples were satisfactorily achieved.
Selectivity
The selectivity of the method toward the endogenous plasma matrix was assessed with the plasma of all dogs. The typical chromatograms are shown in Figure 3 . The retention times of pogostone and IS were 6.1 and 7.4 min, respectively ( Figure 3A and B). The matrix effect of analytes was considered, and no signal interfered under this condition.
Linearity and sensitivity
The peak area ratios of pogostone to IS versus the nominal concentrations exhibited acceptable linearity over the concentration range of 1.02 -406 ng/mL in plasma. The typical regression equation was y ¼ 0.0972x 2 0.1479, r ¼ 0.9949 (where y represents the peak area ratio of pogostone to IS and x represents the concentration of pogostone in plasma). The calibration curve was fitted by linear least-squares regression analysis with a weighting factor of 1/x 2 . The LOQ [signal-to-noise ratio (S/N) ! 5] of pogostone was 1.02 ng/mL.
Precision and accuracy
The intraday accuracy and precision of the method were evaluated by analyzing five replicates at four different QC levels in 1 day, and the interday accuracy and precision were evaluated by analyzing the QC samples in three different days (Table I) . The intra-and interday precision RSDs were within 3.15-5.79 and 2.68-7.13%, respectively. The intra-and interday accuracy ranged from 97.77 to 99.92% and from 98.51 to 100.22%, respectively. The deviations of the mean accuracy were within 15%.
Extraction recovery
The extraction recovery for pogostone and IS were evaluated by assaying two groups of samples: (i) neat standard solutions of pogostone and IS in a solution of methanol, and (ii) extracts from plasma spiked with pogostone and IS. Samples of each group were prepared at three QC levels of LQC, MQC and HQC. By comparing the absolute peak areas of the analytes obtained in Groups 1 and 2, the extraction recoveries of the analytes were calculated as extraction recovery (%) ¼ 100 Â Group 2/Group 1.
The extraction recoveries for pogostone and IS were shown in Table I . The mean recovery of pogostone was 80.61%, which was treated in glass centrifuge tubes during the entire process (n ¼ 15). The mean recovery of the IS was 75.89% (n ¼ 15). The RSDs of these values were ,6%.
Stability
The stability of pogostone was assessed, in terms of short term (at room temperature for 14 h), long term (at 2208C for 21 days), three freeze -thaw cycles (from 2228C to 258C) and autosampler stabilities (at 258C for 12 days). The samples were processed and analyzed with the freshly prepared samples. All stability experiments were performed at three QC levels of LQC, MQC and HQC in triplicate. The plasma samples at three QC concentrations were found to be stable in the stability tests under all of these conditions (Table II) .
Pharmacokinetics
The concentration of pogostone in canine plasma was detectable and quantified up to 16-24 h for all dogs after dosing. Figure 4 depicted the mean plasma pogostone concentration versus time profile in dog plasma. The primary pharmacokinetic parameters are shown in Table III . The results showed that the established method was sensitive enough to detect at least four half-lives of pogostone following its oral administration to beagle dogs at a dose of 1.5 mg/kg.
Discussion
The GC -MS method was successfully used to determine pogostone in canine plasma samples and applied to a pharmacokinetic study. Three organic solvents, diethyl ether, chloroform and ethyl acetate, were evaluated regarding the extraction recovery. Ethyl acetate was found to be more efficient with a recovery rate of 80% compared with diethyl ether (50%), and lower toxicity compared with chloroform.
It was worthwhile to note that the extraction recovery rates of pogostone were high in glass centrifuge tubes. Plastic centrifuge tubes, however, were avoided in this study because of the adsorption effect of pogostone on the inner surface. The extraction recovery rates using plastic centrifuge tubes (Better Biotechnology Co., Ltd, Jiangsu, China) during the sample treatment were much lower and with big error (Table I) . When pogostone was dissolved in organic solvents (hexane and ethyl acetate) and vibrated in a vortex shaker, there was also a loss observed. It has been proposed that adsorption of various drugs to plastic infusion bags acted as a function of time (21, 22) . Dahlstrom et al. (23) studied the adsorption of medetomidine to hydrophilic polystyrene plastic. That study found that the electrostatic binding was the most important mechanism for surface interaction. Another study (24) found that the lipophilicity of compounds explained the adsorption of drugs to polystyrene plastic surface. All these results indicated that a loss of pogostone occurred by surface adsorption maybe through lipophilic interactions.
Conclusions
A simple and selective GC -MS method for the quantification of pogostone in dog plasma was developed and validated. The plasma sample treatment was a one-step liquid -liquid extraction procedure with high extraction recovery rates by avoiding use of plastic centrifuge tubes. The desired sensitivity was achieved, with an LOQ of 1.02 ng/mL. This method had been successfully applied to a pharmacokinetic study following a single-dose oral administration of pogostone (1.5 mg/kg) to beagle dogs. Bias (%) ¼ (the absolute value of mean measured concentration of stability sample minus freshly prepared sample/measured concentration of freshly prepared sample) Â 100.
